Knee Injuries Completed Phase 2 / 3 Trials for Dexmedetomidine (DB00633)

Also known as: Knee Injury / Injuries, Knee / Injury, Knee / Joint injury

IndicationStatusPhase
DBCOND0031346 (Knee Injuries)Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03212495Intra-articular Dexmedetomidine Versus Neostigmine After Knee Arthroscopy (a Comparative Study)Treatment